C Ansah
Department of Pharmacology, Faculty of Pharmacy, College of Health Sciences, Kwame Nkrumah University of Science & Technology, Kumasi, Ghana
NJ Gooderham
Molecular Toxicology, Division of Biomedical Sciences, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, Exhibition Road, London, SW7 2AZ, UK
Abstract
Cryptolepine (CLP), the major alkaloid of the West African anti-malarial plant Cryptolepis sanguinolenta is a known in vitro mammalian cytotoxin and a DNA intercalator. We have been studying the potential toxicity of CLP and the aqueous anti-malarial formulation (CSE) to mammalian cells in vitro. The objective of the present study was to determine if the cytotoxicity of CLP is as a result of metabolic activation and reactive oxygen species (ROS) generation. Involvement of metabolic activation was assessed by studying the differential toxicity of CLP to MCL-5 and cHoL, two human lymphoblastoid cell lines differing only in their metabolic competencies. ROS determination was performed using the fluorescent probe 2\', 7\'-dichlorofluorescein-diacetate (DCFH-DA), a dye commonly used to measure intracellular changes in ROS. In a Trypan blue exclusion assay, there was no difference between the growth curves of the two cell lines after exposure to CSE (5-100μg/ml) or CLP (0.5-5.0μM) for 24 hours under similar experimental conditions. Further, in an enzyme inhibition assay, CLP at 2.5μM reduced the viability of MCL-5 cells by 30% but the effect of CLP in the presence of inhibitors did not differ significantly from that of CLP alone. In contrast, both CSE and CLP caused a dose-dependent increase in ROS production, which reduced significantly following pre-treatment with N-acetylcysteine, an anti-oxidant. The results together suggest that CLP is a direct cytotoxin that readily generates damaging ROS.
Keywords: cryptolepine, cytotoxicity, metabolic activation, reactive oxygen species
Journal Of Science And Technology Vol. 25 (1) 2005: 1-10